Back to News
Market Impact: 0.25
Multiply Labs Raises $75 Million Series B to Close the Gap Between Drug Discovery and Drug Manufacturing
Source: Business Wire
Private Markets & VentureHealthcare & BiotechTechnology & Innovation
Multiply Labs raised $75 million in a Series B led by Dr. Patrick Soon-Shiong. The company said it will use the funding to scale robotic manufacturing aimed at expanding patient access to next-generation drugs.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
More News
- Singapore's Temasek warns of the ‘biggest risk’ facing markets right now
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- What Marvell's rosy long-term guidance means for our AI chip stocks
- Malaysia 2027 budget to tackle living costs, fiscal risks as election looms
- Meta may ditch the idea of a cloud business for Muse. We think that’s a good trade
- Why is Telix Pharmaceuticals stock rallying today?